Adult Attention Deficit and Hyperactivity Disorder and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Adult Attention Deficit and Hyperactivity Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adult Attention Deficit and Hyperactivity Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adult Attention Deficit and Hyperactivity Disorder Overall Market Size
2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Size: 2021 VS 2028
2.2 Global Adult Attention Deficit and Hyperactivity Disorder Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adult Attention Deficit and Hyperactivity Disorder Players in Global Market
3.2 Top Global Adult Attention Deficit and Hyperactivity Disorder Companies Ranked by Revenue
3.3 Global Adult Attention Deficit and Hyperactivity Disorder Revenue by Companies
3.4 Top 3 and Top 5 Adult Attention Deficit and Hyperactivity Disorder Companies in Global Market, by Revenue in 2021
3.5 Global Companies Adult Attention Deficit and Hyperactivity Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adult Attention Deficit and Hyperactivity Disorder Players in Global Market
3.6.1 List of Global Tier 1 Adult Attention Deficit and Hyperactivity Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Adult Attention Deficit and Hyperactivity Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Adult Attention Deficit and Hyperactivity Disorder Market Size Markets, 2021 & 2028
4.1.2 Stimulant
4.1.3 Non-stimulant
4.2 By Type - Global Adult Attention Deficit and Hyperactivity Disorder Revenue & Forecasts
4.2.1 By Type - Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2022
4.2.2 By Type - Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2023-2028
4.2.3 By Type - Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adult Attention Deficit and Hyperactivity Disorder Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Adult Attention Deficit and Hyperactivity Disorder Revenue & Forecasts
5.2.1 By Application - Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2022
5.2.2 By Application - Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2023-2028
5.2.3 By Application - Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Adult Attention Deficit and Hyperactivity Disorder Market Size, 2021 & 2028
6.2 By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue & Forecasts
6.2.1 By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2022
6.2.2 By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2023-2028
6.2.3 By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2028
6.3.2 US Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.3.3 Canada Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.3.4 Mexico Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2028
6.4.2 Germany Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4.3 France Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4.4 U.K. Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4.5 Italy Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4.6 Russia Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4.7 Nordic Countries Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.4.8 Benelux Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2028
6.5.2 China Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.5.3 Japan Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.5.4 South Korea Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.5.5 Southeast Asia Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.5.6 India Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2028
6.6.2 Brazil Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.6.3 Argentina Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2028
6.7.2 Turkey Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.7.3 Israel Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.7.4 Saudi Arabia Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
6.7.5 UAE Adult Attention Deficit and Hyperactivity Disorder Market Size, 2017-2028
7 Players Profiles
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.1.4 Takeda Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.1.5 Takeda Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.2.4 Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.3.4 Novartis Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.4.4 Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.4.5 Eli Lilly Key News
7.5 Tris Pharma
7.5.1 Tris Pharma Corporate Summary
7.5.2 Tris Pharma Business Overview
7.5.3 Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.5.4 Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.5.5 Tris Pharma Key News
7.6 Neos Therapeutics
7.6.1 Neos Therapeutics Corporate Summary
7.6.2 Neos Therapeutics Business Overview
7.6.3 Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.6.4 Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.6.5 Neos Therapeutics Key News
7.7 Mallinckrodt
7.7.1 Mallinckrodt Corporate Summary
7.7.2 Mallinckrodt Business Overview
7.7.3 Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.7.4 Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.7.5 Mallinckrodt Key News
7.8 Amneal Pharmaceuticals
7.8.1 Amneal Pharmaceuticals Corporate Summary
7.8.2 Amneal Pharmaceuticals Business Overview
7.8.3 Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.8.4 Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.8.5 Amneal Pharmaceuticals Key News
7.9 Noven Pharmaceuticals
7.9.1 Noven Pharmaceuticals Corporate Summary
7.9.2 Noven Pharmaceuticals Business Overview
7.9.3 Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.9.4 Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.9.5 Noven Pharmaceuticals Key News
7.10 Purdue Parma
7.10.1 Purdue Parma Corporate Summary
7.10.2 Purdue Parma Business Overview
7.10.3 Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.10.4 Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.10.5 Purdue Parma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Adult Attention Deficit and Hyperactivity Disorder Market Opportunities & Trends in Global Market
Table 2. Adult Attention Deficit and Hyperactivity Disorder Market Drivers in Global Market
Table 3. Adult Attention Deficit and Hyperactivity Disorder Market Restraints in Global Market
Table 4. Key Players of Adult Attention Deficit and Hyperactivity Disorder in Global Market
Table 5. Top Adult Attention Deficit and Hyperactivity Disorder Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Adult Attention Deficit and Hyperactivity Disorder Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Share by Companies, 2017-2022
Table 8. Global Companies Adult Attention Deficit and Hyperactivity Disorder Product Type
Table 9. List of Global Tier 1 Adult Attention Deficit and Hyperactivity Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adult Attention Deficit and Hyperactivity Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Adult Attention Deficit and Hyperactivity Disorder Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Adult Attention Deficit and Hyperactivity Disorder Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Adult Attention Deficit and Hyperactivity Disorder Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Adult Attention Deficit and Hyperactivity Disorder Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 32. Takeda Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 35. Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 38. Novartis Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 41. Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 42. Tris Pharma Corporate Summary
Table 43. Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 44. Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 45. Neos Therapeutics Corporate Summary
Table 46. Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 47. Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 48. Mallinckrodt Corporate Summary
Table 49. Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 50. Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 51. Amneal Pharmaceuticals Corporate Summary
Table 52. Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 53. Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 54. Noven Pharmaceuticals Corporate Summary
Table 55. Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 56. Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 57. Purdue Parma Corporate Summary
Table 58. Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Product Offerings
Table 59. Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Adult Attention Deficit and Hyperactivity Disorder Segment by Type in 2021
Figure 2. Adult Attention Deficit and Hyperactivity Disorder Segment by Application in 2021
Figure 3. Global Adult Attention Deficit and Hyperactivity Disorder Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adult Attention Deficit and Hyperactivity Disorder Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adult Attention Deficit and Hyperactivity Disorder Revenue in 2021
Figure 8. By Type - Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 9. By Application - Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 10. By Region - Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 11. By Country - North America Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 12. US Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 16. Germany Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 17. France Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 24. China Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 28. India Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 30. Brazil Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 33. Turkey Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Adult Attention Deficit and Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
